09:39 AM EDT, 06/27/2025 (MT Newswires) -- Bone Biologics ( BBLG ) said Friday it priced a public offering of 1.25 million shares and accompanying series D and series E warrants at $4 per unit for expected gross proceeds of $5 million.

The biotechnology company said the series D and E warrants, both exercisable immediately at $4 per share, will expire in five years and 18 months, respectively.

The company said the warrants could generate up to $10 million in additional proceeds if exercised for cash.

Bone Biologics ( BBLG ) said it plans to use the net proceeds to support clinical development, intellectual property expenses, and general operations. The offering is expected to close on Monday.

Shares of the company were up more than 39% in early Friday trading.

Price: 5.81, Change: +1.65, Percent Change: +39.66